Name The Lancet Oncology

View Statistics Email Alert RSS Feed

Refined By:

Structure: departamento de ciencias médicas y quirúrgicas

Title Issue Date
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Garassino, Marina C.; Gadgeel, Shirish; Esteban, Emilio; Felip, Enriqueta; Speranza, Giovanna, et al Issued date: 2020 DOI: 10.1016/S1470-2045(19)30801-0 Source: Lancet Oncology[ISSN 1470-2045],v. 21 (3), p. 387-397, (Marzo 2020) SJR: 13,53 - Q1 JCR: 41,316 - Q1 SCIE Artículo

Garassino, Marina C.; Gadgeel, Shirish; Esteban, Emilio; Felip, Enriqueta; Speranza, Giovanna, et al

Issued date: 2020

DOI: 10.1016/S1470-2045(19)30801-0

Source: Lancet Oncology[ISSN 1470-2045],v. 21 (3), p. 387-397, (Marzo 2020)

SJR: 13,53

- Q1

JCR: 41,316

- Q1

SCIE

Artículo